eCOA Resources
-
A Purpose-Built eCOA: Reduce Site And Patient Burden In Gastroenterology Trials
9/19/2022
Learn how a purpose-built solution designed to overcome the significant, but typical, challenges of a complex GI trial enables improved trial conduct and a better deployment experience.
-
Medable's Japanese Clinical Trial Exceeds FPI Date And eCOA Adherence
3/10/2025
A top-10 global pharma company aimed to address eCOA adherence and patient enrollment challenges faced by clinical trial sites in Japan. Explore an initiative to enhance the patient and site experience.
-
eCOA In Oncology Trials: A Tool To Simplify
10/16/2025
Accurate quality of life data is critical in oncology. eCOA unified with IRT streamlines trials, improves data collection, and enhances site user experiences across therapeutic areas.
-
Rapid Study Design With The Sculptor Portal
4/2/2025
Accelerate your eCOA assessment design to streamline UAT, mid-study updates, and protocol amendments effortlessly.
-
Paper vs. eCOA: Hard Calculations For Easy Decisions
6/13/2023
Sticker prices often guide purchases, but there's a broader perspective that encompasses total cost. Use this calculator to compare prices of paper COAs or eCOAs, including ePROs, eDiaries, and eClinROs.
-
Leveraging Tech And Clinician Review To Improve Risk Detection
10/19/2023
Learn why neuroscience therapy developers should start adopting strategies to improve data quality and assess responses using a combination of technology and expert clinician review.
-
Harness The Power Of eCOA In Your Next Trial
In this webinar, explore the importance of eCOAs, how they have evolved from the standard paper diaries, and what efficiencies you can realize from them.
-
Empowering Oncology Research With The Right Technology Solutions
10/25/2023
Explore how advanced technology solutions have the potential to simplify the operational aspects of oncology trials.
-
Building A Scalable Oncology Engine In A Dynamic Market
6/3/2026
Learn how a top-10 global pharmaceutical company partnered with Medable to rapidly scale the number of oncology trials it could concurrently conduct.
-
Optimizing Prader-Willi Syndrome Clinical Trials
10/21/2024
Learn how Signant is helping to mitigate placebo responses and ensuring high-quality data to improve Prader-Willi syndrome (PWS) clinical trial success.